StemCell Therapy

Baxter International Inc.

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has begun testing the waters of clinical sequencing, and five of the grants it announced Tuesday as part of its revamped Genome Sequencing Program mark its first steps toward pursuing DNA sequencing in the clinic.

British researchers claim to have created stem cells of a “gold standard” quality that could lead to a new wave of treatments for degenerative diseases. Taken from human embryos, they could be available to researchers before the end of next year for eventual use in clinical trials, The Daily Telegraph reported Tuesday.

BERLIN: World boxing champion Vladimir Klitschko on Tuesday insisted he suffered the worst pain of his life after needing surgery to remove kidney stones which forced him out of his bout with France’s Jean–Marc Mormeck.

Accra , Nov 30, GNA – Ghana’ Agriculture Minister Mr. Kwesi Ahwoi on Tuesday said the country would pay attention to all areas where biotechnology would be useful to improve productivity.

SAN DIEGO — The Sanford Consortium for Regenerative Medicine will open a new collaborative research building on Tuesday, November 29, at a 9:00 a.m. ceremony that will formally launch California’s newest …

Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.

Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.

Editor’s note: This essay, by renowned evolutionary biologist Lynn Margulis, was published in the August 1994 issue of Scientific American with the title, ” Sex, Death and Kefir .” Margulis died on Tuesday in her home, according to a statement released by the University of Massachusetts at Amherst, where she was a Distinguished University Professor of Geosciences. She is best known for her work …

A DELEGATION of Brazilian scientists will be in the beef capital of Australia on Tuesday to look at some of Queensland’s best practices in bovine genetics.

The North Carolina Zoo’s oldest male elephant underwent eye surgery on Tuesday, according to zoo officials.

A U.S. drug company suddenly halted the world’s first official trial using human embryonic stem cells for financial reasons Tuesday in a decision that immediately sparked “disgust” from spinal injury charities and others hoping to benefit from the research.

The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs and the company will focus instead on new cancer treatments, Geron said Tuesday.

Shares of stem cell therapy pioneer Geron Corp. plunged Tuesday morning after the company said it would abandon stem cell research because of the high costs and commercial uncertainties for the field.

INDIANAPOLIS — Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc

Leading researchers from across the country came together in Rapid City to discuss the latest research in carbon nano materials. About seventy people attended the three day conference at the Radisson Hotel, that concluded Tuesday.

Scientists said Tuesday they had transformed age-worn cells in people over 90 — including a centenarian — into rejuvenated stemcells that were “indistinguishable” from those found in embryos.

Bernice Strange will receive the ‘Caregiver of the Year’ award at the American Kidney Fund’s third annual gala, The Hope Affair, on Tuesday, October 25, 2011, in Washington, DC.

The European Union’s highest court ruled Tuesday that scientists cannot patent stem cell techniques that use human embryos for research, a decision some scientists said could threaten major medical advances if it prevents biotech companies from turning a profit.

The European Union’s top court ruled Tuesday that scientists cannot patent stem cell techniques that use human embryos for research, a decision that some scientists said could threaten major medical advances if it prevents biotech companies from turning a profit.